Clinical Trial Update: A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 randomized study evaluating safety and efficacy of Pazopanib plus Gemcitabine in persistent or relapsed ovarian cancer (and related fallopian tube/perit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pazopanib (Pazopanib)

Snippet

Sponsor: Linda R Duska | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-02-25